Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

Clinical trial NCT04514497 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04514497
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Lung Small Cell Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Neuroendocrine Carcinoma Metastatic Pancreatic Adenocarcinoma Stage III Lung Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Lung Small Cell Carcinoma Unresectable Malignant Solid Neoplasm Unresectable Neuroendocrine Carcinoma Unresectable Pancreatic Adenocarcinoma

Start date: 2021-10-20
Primary completion: 2025-02-15
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.